Dr. Mazhar Ahmed Afaq, MD

Dr. Afaq practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Afaq's NPI, 1194922013, was assigned on July 3, 2007. Dr. Afaq holds Kansas license 04-41380.

Dr. Afaq's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Afaq's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Afaq is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Afaq to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afaq practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Afaq's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Afaq's licenses on file in 2 states: Kansas and Missouri.

CMS data shows 1,378 Medicare services from Dr. Afaq across 12 procedure codes in 2024, for 681 Medicare patients. Medicare paid $70,356 for them.

CMS counts 681 Medicare patients who saw Dr. Afaq in 2024. The largest group is 65 to 74, with 314 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Afaq's median patient age at 74, with 48% women.

In 2024, Dr. Afaq wrote 3,114 Medicare Part D claims for 515 patients. 86% of them were for generic drugs. CMS names the drug for 2,853 of them, across 31 drugs with 11 or more claims each, at $419,019 in total drug cost. In 2023, CMS named 2,221 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Afaq for performance year 2024, reported through an alternative payment model (APM). Dr. Afaq accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Afaq as offering telehealth.

Dmand AI links 3 papers to Dr. Afaq, published from 2013 to 2024. Dr. Afaq's most frequent co-authors are Lawrence Bernstein, Tarun Dalia, MBBS, MD and Doantrang T. Du, MD.

CMS Open Payments shows 140 general payments to Dr. Afaq from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $1,211.